US Edition
Life Science Companies Step Into the D2C Space: A New Era of Access and Innovation
Summary by MRINetwork
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Life Science Companies Step Into the D2C Space: A New Era of Access and Innovation
Life science companies typically operate through B2B models. They sell to labs, healthcare systems, and hospitals. However, consumer demands have changed, encouraging life science brands to enter the direct-to-consumer (D2C) space. The need for faster access to healthcare solutions, technological advancements, and the opportunities surrounding profits and consumer data all play a role. As a result, product development, marketing, and talent nee…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium